StockData
Verastem, Inc. logo

Verastem, Inc. (VSTM) stock

VSTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$7.41−0.29 (-3.77%)

Close on Nov 17, 2026Market cap $671.08MP/E –Yield –

Verastem r&d expenses

Research and development expenses are spending on new products and technology.

Verastem's R&D Expenses for the twelve months ending Jun 30, 2026 was $140.22M. For fiscal 2025 it was $114.60M, up 40.9% from the year before. Over ten years it grew 10.9% a year on average. The highest annual figure on record is $114.60M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$114.60M+40.9%
FY2024Dec 31, 2024$81.33M+32.6%
FY2023Dec 31, 2023$61.36M+21.4%
FY2022Dec 31, 2022$50.56M+28.5%
FY2021Dec 31, 2021$39.35M-4.9%
FY2020Dec 31, 2020$41.38M-9.6%
FY2019Dec 31, 2019$45.78M+4.9%
FY2018Dec 31, 2018$43.65M-6.0%
FY2017Dec 31, 2017$46.42M+134.7%
FY2016Dec 31, 2016$19.78M-51.2%
FY2015Dec 31, 2015$40.57M+14.4%
FY2014Dec 31, 2014$35.45M+36.7%
FY2013Dec 31, 2013$25.93M+19.4%
FY2012Dec 31, 2012$21.71M+119.7%
FY2011Dec 31, 2011$9.88M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$41.34M+66.8%
Q1 FY2026Mar 31, 2026$38.22M+31.1%
Q4 FY2025Dec 31, 2025$31.67M+52.2%
Q3 FY2025Sep 30, 2025$28.99M-19.0%
Q2 FY2025Jun 30, 2025$24.79M+10.2%
Q1 FY2025Mar 31, 2025$29.15M+109.0%
Q4 FY2024Dec 31, 2024$20.81M+61.4%
Q1 FY2024Jun 30, 2024$35.77M+197.7%
Q4 FY2023Dec 31, 2023$22.50M+109.5%
Q3 FY2023Sep 30, 2023$13.95M+23.5%
Q2 FY2023Jun 30, 2023$12.89M-13.4%
Q1 FY2023Mar 31, 2023$12.02M-11.9%
Q4 FY2022Dec 31, 2022$10.74M-5.8%
Q3 FY2022Sep 30, 2022$11.29M+21.1%
Q2 FY2022Jun 30, 2022$14.89M+53.0%
Q1 FY2022Mar 31, 2022$13.64M+53.3%
Q4 FY2021Dec 31, 2021$11.40M+12.2%
Q3 FY2021Sep 30, 2021$9.33M-14.9%
Q2 FY2021Jun 30, 2021$9.73M+4.1%
Q1 FY2021Mar 31, 2021$8.90M-18.6%
Q4 FY2020Dec 31, 2020$10.15M-18.5%
Q3 FY2020Sep 30, 2020$10.96M-10.3%
Q2 FY2020Jun 30, 2020$9.34M-17.6%
Q1 FY2020Mar 31, 2020$10.92M+11.9%
Q4 FY2019Dec 31, 2019$12.46M+42.1%
Q3 FY2019Sep 30, 2019$12.22M+5.6%
Q2 FY2019Jun 30, 2019$11.35M-8.4%
Q1 FY2019Mar 31, 2019$9.76M-10.8%
Q4 FY2018Dec 31, 2018$8.76M-22.1%
Q3 FY2018Sep 30, 2018$11.57M-34.8%
Q2 FY2018Jun 30, 2018$12.38M+36.9%
Q1 FY2018Mar 31, 2018$10.93M+30.4%
Q4 FY2017Dec 31, 2017$11.25M+63.3%
Q3 FY2017Sep 30, 2017$17.74M+320.8%
Q2 FY2017Jun 30, 2017$9.04M+101.3%
Q1 FY2017Mar 31, 2017$8.39M–
Q4 FY2016Dec 31, 2016$6.89M–
Q3 FY2016Sep 30, 2016$4.22M–
Q2 FY2016Jun 30, 2016$4.49M–

More Verastem figures

See a number that looks wrong?